Guilherme Perini, MD
@GuiperiniMD
Followers
3K
Following
4K
Media
217
Statuses
3K
Hematologist in Sao Paulo, Brazil. Focus on Lymphomas and CLL Host: Fase 3 Podcast
Sao Paulo, Brazil
Joined August 2020
You have to be always drunk. That's all there is to it; it's the only way. So as not to feel the horrible burden of time that breaks your back and bends you to the earth, you have to be continually drunk. But on what? Wine, poetry or virtue, as you wish. But be drunk. Baudelaire.
0
0
23
RT @majorajay: Survival after incidental vs symptomatic FL:.- 908 pts, 29% incidental.- incidental: more early stage & normal LDH.- no diff….
0
12
0
Interestingly, kiskadee in Brazil is called Bem-te-vi. Both names reflect the sound of the bird singing. I have 3 that come to my house to have breakfast with me everyday. Lovely birds.
Great kiskadee, a type of flycatcher with breathtaking colors (Spittal Pond, Bermuda) #birds #birding #nature
0
0
4
This is 👌.
I tried to walk like an Egyptian and now I need to see a Cairo practor.
0
0
1
Ok. But it needs to include TMTV in the analysis otherwise we are selecting better patients for radiotherapy.
🆕 Radiation Bridging (bRT) Before CAR‑T in r/r DLBCL – Update. 💥 Why bRT?.•Controls disease during manufacturing → avoids progression before infusion .•Helps reduce bulky or hypoxic tumor burden and improve CAR‑T efficacy . ⸻. 📈 Key Outcomes:.•ORR ~82% at 30 days.
1
0
5
Just had one of my ph3 trials in R/R DLBCL stopped due to concerns on the control arm (R-GEMOX). We are now in a loophole:.R-Gemox is not SoC.Glofi-Gemox is not FDA Approved.Pola-R-Gemox has 75% of pts enrolled outside US and Europe.Both Polargo and Sumo tested x RGEMOX.
1
6
31
Jokes aside: Come on #ASH25. 85 USD is a lot of money for LMIC fellows and residents!. Think Globally!.
0
1
8
Just finished submitting all my abstracts to #ASH25. Do you think I will complain about the 85 Dollar fee even for LMIC?. Of course not. I have my fund reserve to help me.
2
0
13
Today is the International Day of "I will never leave this for the last minute again"!. Stay strong, my fellow hematologists. #ASH25.
2
3
36
💚🤍❤️.
0
0
10
This is a huge finding and highlights the need to better separate the multiple faces of Agressive B-Cell lymphomas.
0
0
4
Looks like Glofi-GemOX is a no go from the FDA standpoint. @JulioChavezMD @lymphomaphilia @JuanAlderuccio @bshah @iHematologo @GuiperiniMD @KrishPatelMD. Was there any hope left s/p ODAC?.
0
0
1
RT @GomezDLeonMD: Last month I had the opportunity to visit Hospital Israelita Albert Einstein in Saõ Paulo 🇧🇷 and I was very impressed. W….
0
4
0
It's a New era in ODAC, it seems. Maybe good for the "contrarians", but terrible for our patients. What a shame.
Shocker for me. ODAC votes against belantamab risk benefit for myeloma. I hope that this vote reflects the way the questions were narrowly worded. I still hope the drug still gets FDA approved.
0
2
9
This is going to be AMAZING! DONT MISS IT!.
Mark your calendar for the 6th Meeting / Latin American Group on CLL on April 2026 in beautiful Mendoza!! .With regional and international speakers with cheese and wine (Malbec) posters reception ✅
1
0
17
I will no longer use EPOCH. I will be using HOPE-C. Great article, btw.
👏 I saw an interesting anecdote and just looked up the reference. Literally before I was born, an oncologist very succinctly and elegantly summarized how we offer hope to our patients living with cancer. these words are still true today!.
3
6
41
2025 and people still debating EPOCH in DHL.
Waleed Alduaij at #icmlugano last week presented this well conducted retrospective study from British Columbia on double hit lymphoma, suggesting a large benefit from DA EPOCHR vs RCHOP. But the PFS separation is very early, mostly <3 months.
2
1
9
The legend, the Hodgkin killer, the one and only Matthew Mei is visiting us in Brazil! . What an honor! .@fabiopss @matthew_mei
1
2
30
